Del. Judge OKs KaloBios Ch. 11 Disclosure, Investor Pact

By Jeff Montgomery (May 6, 2016, 9:21 PM EDT) -- KaloBios Pharmaceuticals, formerly helmed by indicted CEO Martin Shkreli, won approval for its Chapter 11 disclosure and schedule Friday, after approval of a settlement with prepetition equity buyers and the temporary sidelining of recovery efforts by a former director who also invested days before the company's collapse....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!